Beacon Pointe Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Beacon Pointe Advisors, LLC

$9.37 Billion
Q2 2025

A detailed history of Beacon Pointe Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 19,467 shares of REGN stock, worth $12.7 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

19,467

Previous 19,515 0.25%

Holding current value

$12.7 Million

Previous $12.4 Million 17.42%

% of portfolio

0.11%

Previous 0.14%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$483.07 - $625.6 $23,187 - $30,028	-48 Reduced 0.25%	19,467 $10.2 Million
Q1 2025 May 13, 2025	SELL	$634.14 - $744.83 $102,096 - $119,917	-161 Reduced 0.82%	19,515 $12.4 Million
Q4 2024 Feb 14, 2025	SELL	$701.85 - $1046.91 $298,286 - $444,936	-425 Reduced 2.11%	19,676 $14 Million
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $2.22 Million - $2.61 Million	-2,169 Reduced 9.74%	20,101 $21.1 Million
Q2 2024 Aug 12, 2024	SELL	$883.2 - $1071.19 $291,456 - $353,492	-330 Reduced 1.46%	22,270 $23.4 Million
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $167,900 - $184,763	-186 Reduced 0.82%	22,600 $21.8 Million
Q4 2023 Feb 08, 2024	SELL	$775.18 - $881.7 $810,063 - $921,376	-1,045 Reduced 4.39%	22,786 $20 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $871,794 - $1.06 Million	1,259 Added 5.58%	23,831 $19.6 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $1.54 Million - $1.83 Million	-2,207 Reduced 8.91%	22,572 $16.2 Million
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $4.86 Million - $5.91 Million	-7,144 Reduced 22.38%	24,779 $20.4 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $2.97 Million - $3.23 Million	4,210 Added 15.19%	31,923 $23 Million
Q3 2022 Nov 09, 2022	SELL	$573.97 - $724.32 $194,001 - $244,820	-338 Reduced 1.2%	27,713 $19.1 Million
Q2 2022 Aug 11, 2022	SELL	$548.35 - $738.84 $273,626 - $368,681	-499 Reduced 1.75%	28,051 $16.6 Million
Q1 2022 May 17, 2022	BUY	$595.12 - $698.43 $2.14 Million - $2.52 Million	3,603 Added 14.44%	28,550 $19.9 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $2.23 Million - $2.75 Million	-4,104 Reduced 14.13%	24,947 $15.8 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $12.6 Million - $14.9 Million	21,898 Added 306.14%	29,051 $17.6 Million
Q2 2021 Aug 17, 2021	BUY	$472.8 - $558.54 $3.38 Million - $4 Million	7,153 New	7,153 $4 Million

Others Institutions Holding REGN

# of Institutions

1,439

Shares Held

88.9M

Call Options Held

1.98M

Put Options Held

1.75M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $69.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.

Account

Beacon Pointe Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History